Literature DB >> 7489805

Central sleep apnoea, pathogenesis and treatment: an overview and perspective.

W A De Backer1.   

Abstract

The prevalence of reported sleep disturbances in a general population is high. Many of the complaints are the result of sleep-related breathing disorders, due mainly to the occurrence of obstructive and central apnoeas. Obstructive sleep apnoea is a fully described and well-recognized entity. Central sleep apnoea (CSA) however, has been poorly studied. There is accumulating evidence that central sleep apnoea should be considered as the end of a spectrum. Instability in the breathing pattern is the main underlying mechanism and is due to the interaction of many factors. Breathing during sleep is dependent on metabolic control and the activity of the respiratory muscles. Decreased chemical drive and/or failing respiratory muscle function are associated with CSA and usually also with ongoing hypoventilation during wakefulness, characterized by chronic daytime hypercapnia. Central respiratory drive can also be inhibited by upper airway reflexes. Mostly, however, CSA occurs as the hallmark of unstable breathing during sleep brought about by an overall increase in loop gain (especially in light sleep stages) and the unmasking of a CO2 threshold. Arousal following central apnoeas acts as an amplification of the instability. Micro electroencephographic (EEG) arousals are often observed as a consequence of CSA. They are responsible for sleep fragmentation and hypersomnolence during the day. The daytime hypersomnolence and complaints of awakenings during sleep in patients with CSA can be striking. CSA can occur in specific pathologies, such as chronic heart failure and (post-traumatic) brain lesions, that are associated with irregular breathing. Treatment strategies are remarkably few in number. Use of nasal ventilation and the inhalation of CO2 are mainly of theoretical interest, since patients do not often tolerate these more invasive therapies. Drug treatment, especially with acetazolamide, is easier to perform. Stimulation of upper airway reflexes, by less invasive methods, seems to be promising for the near future.

Entities:  

Mesh:

Year:  1995        PMID: 7489805     DOI: 10.1183/09031936.95.08081372

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

Review 1.  Sleep-disordered breathing and cognition in older adults.

Authors:  Molly E Zimmerman; Mark S Aloia
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

2.  [Guidelines for home oxygen and home ventilation therapy. German Society of Pneumology, German Society of Sleep Medicine, Working Group of Nocturnal Respiratory and Cardiovascular Disorders, Working Circle of Home and Long-Term Ventilation].

Authors:  D Köhler; C P Criée; F Raschke
Journal:  Med Klin (Munich)       Date:  1997-01-15

Review 3.  Central sleep apnoea-a clinical review.

Authors:  Rexford T Muza
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

4.  Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution.

Authors:  Stijn L Verhulst; Nancy Schrauwen; Dominique Haentjens; Bert Suys; Raoul P Rooman; Luc Van Gaal; Wilfried A De Backer; Kristine N Desager
Journal:  Arch Dis Child       Date:  2006-10-13       Impact factor: 3.791

5.  Reduced respiratory neural activity elicits a long-lasting decrease in the CO2 threshold for apnea in anesthetized rats.

Authors:  N A Baertsch; T L Baker
Journal:  Exp Neurol       Date:  2016-07-26       Impact factor: 5.330

Review 6.  The impact of spinal cord injury on breathing during sleep.

Authors:  David D Fuller; Kun-Ze Lee; Nicole J Tester
Journal:  Respir Physiol Neurobiol       Date:  2013-06-17       Impact factor: 1.931

Review 7.  Heart failure and sleep disorders.

Authors:  Gianfranco Parati; Carolina Lombardi; Francesco Castagna; Paola Mattaliano; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Nat Rev Cardiol       Date:  2016-05-12       Impact factor: 32.419

8.  Treatment of sleep apnea in congestive heart failure with a dental device: the effect on brain natriuretic peptide and quality of life.

Authors:  Mahmoud Eskafi; Charles Cline; Maria Nilner; Bo Israelsson
Journal:  Sleep Breath       Date:  2006-06       Impact factor: 2.816

9.  A case of central sleep apnea strictly dependent upon REM-sleep.

Authors:  Armin Steffen; Johann Hagenah; Barbara Wollenberg; Norbert Brüggemann
Journal:  J Neurol       Date:  2010-01       Impact factor: 4.849

Review 10.  Sleep disordered breathing in chronic heart failure.

Authors:  Austin Chin Chwan Ng; Saul Benedict Freedman
Journal:  Heart Fail Rev       Date:  2008-06-12       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.